About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT00989209

Myofunctional Therapy in Facial Palsy

Objective: Quantify the benefits of myofunctional therapy associated to botulinum toxin injection in patients with long standing facial unilateral palsy.

Lead sponsor: University of Sao Paulo General Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Sao Paulo General Hospital

Twenty-five patients with long standing facial palsy were studied; all had been previously treated for facial reanimation. Patients were randomly divided in two groups; Group A did the myofunctional therapy sessions with the speech therapist before the botulinum toxin injection, while the participants of Group B did the myofunctional therapy after it.

Age

16 - 62 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•facial paralysis with more than 2 years elapsed since the onset of symptoms
•surgically treated for reanimation at least 12 months before
•static and/or dynamic facial asymmetry causing aesthetic concern

Exclusion Criteria

•spastic paralysis
•serious systemic or neuromuscular diseases
•cognition impairment
•pregnant women

Related studies

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

NCT06335719 · Facial Paralysis

The Relationship Between Idiopathic Acute Peripheral Facial Paralysis and Homocysteine Level in Adult Patients

NCT06742580 · Facial Paralysis, Peripheral, Bell Palsy

Functional Recovery From Facial Paralysis

NCT06532903 · Peripheral Facial Paralysis, Facial Palsy, and more

Clinical Study on the End Time of Acupuncture and Moxibustion Therapy for Peripheral Facial Paralysis

NCT06393231 · Peripheral Facial Paralysis

COMPLETEDPhase 3

Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis

NCT05945615 · Blepharoptosis, Synkinesis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 5, 2009Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment25

Start dateJan 2005

Last updatedOct 5, 2009

Condition

Facial Paralysis

Locations shown

University of Sao Paulo General Hospital

São Paulo, São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 5, 2009Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions